• 研究課題をさがす
  • 研究者をさがす
  • KAKENの使い方
  1. 課題ページに戻る

2021 年度 実施状況報告書

APPLICATION OF RvD2 AS A REGENERATIVE DIRECT PULP CAPPING MATERIAL

研究課題

研究課題/領域番号 20K09938
研究機関岡山大学

研究代表者

アリアス・マルティネス スレマ・ロサリア  岡山大学, 医歯薬学域, 助教 (70824580)

研究分担者 大森 一弘  岡山大学, 大学病院, 講師 (20549860)
山城 圭介  岡山大学, 大学病院, 講師 (30581087) [辞退]
高柴 正悟  岡山大学, 医歯薬学域, 教授 (50226768)
研究期間 (年度) 2020-04-01 – 2023-03-31
キーワードVital pulp therapy / Resolving D2 / Reparative dentin / Dental pulp cells
研究実績の概要

Vital pulp therapy (VPT)’s aim is reparative dentin production after pulp injury. Current VPT agents have biocompatibility problems. Previously we proved that RvD2, an anti-inflammatory lipid mediator, produced in vivo from polyunsaturated fatty acids healed apical periodontitis (AP). Having analgesic, angiogenic, bacterial clearance effects, RvD2 is the "ideal VPT agent". In 2020, we reported reparative dentin (RD) after RvD2 and Ca(OH)2 application (rat model). IMH results showed GPR18’s expression in RvD2 group. This year we added this agent in dental pulp cells, finding decreased expression of Tnf-α and Il-1β, suggesting that RvD2 had an anti-inflammatory effect. RvD2 may establish a favorable environment for the formation of RD in the dental pulp by its anti-inflammatory effects.

現在までの達成度 (区分)
現在までの達成度 (区分)

3: やや遅れている

理由

The following goals have been achieved. In vivo experiments, 1) the pulpotomy rat model has been standardized, 2) the dentin bridge regeneration at the pulp injury after RvD2 application as a VPT agent has been found, 3) immunohistochemistry confirmed the presence of GPR18 on RvD2 groups.

In vitro, RvD2 decreased the gene expression level of Tnf-α and Il-1β in dental pulp cells, which results suggested anti-inflammatory effect of RvD2 in dental pulp cells.

Because of COVID-19 pandemic, it was not possible to check all these factors, however some of the obtained results until now were reported at the International Association of Dental Research (IADR) in July 2021.

今後の研究の推進方策

In vitro, to examine the effects of RvD2 on dental pulp cells we will perform using real-time PCR and ELISA the expression of the following markers: anti-inflammatory cytokines (IFN-γ, IL-10, IL-17, TGF-β), inflammatory cytokines (IL-1β, IL-6, IL-8, TNF-α), angiogenesis and tissue regeneration cytokine (VEGF), hard tissue formation (wnt3a, wnt10a, β-catenin), analgesic effect (TRPA1, substance P), dentin related markers (DSPP, DMP-1, alkaline phosphatase, osteocalcin), RvD2 receptor (GPR18). Furthermore, in vivo experiments, we will observe the expression of these marker using immunohistochemistry. However, the results obtained until this year show that the effects of this materials are so amazing to protect the viability of dental pulp. Thus, a manuscript is underway to submit to an international journal, and it is expected to obtain comments and suggestion to improve this study.

次年度使用額が生じた理由

Because of COVID-19 pandemic,it was not possible to conduct the the planned in vivo experiments so we will use the remained money for the experiments next Fiscal Year.

  • 研究成果

    (1件)

すべて 2021

すべて 学会発表 (1件) (うち国際学会 1件)

  • [学会発表] Resolvin D2 Promotes the Formation of Calcified Tissue on Pulp2021

    • 著者名/発表者名
      Mitsuhiro Yoneda, Zulema Rosalia Arias Martinez, Shin Nakamura, Kentaro Okamoto, Masahiro Ito, Kazuya Tamura, Hidetaka Ideguchi, Kazuhiro Omori, Keisuke Yamashiro, Tadashi Yamamoto, Shogo Takashiba.
    • 学会等名
      2021 IADR/ AADR/ CADR General Session
    • 国際学会

URL: 

公開日: 2022-12-28  

サービス概要 検索マニュアル よくある質問 お知らせ 利用規程 科研費による研究の帰属

Powered by NII kakenhi